Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association.

@article{Lefaucheur2006MembranousNA,
  title={Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association.},
  author={Carmen Lefaucheur and B{\'e}n{\'e}dicte Stengel and Dominique Nochy and Paul Martel and Gary S. Hill and Claude Jacquot and J{\'e}r{\^o}me Rossert},
  journal={Kidney international},
  year={2006},
  volume={70 8},
  pages={
          1510-7
        }
}
The association between membranous nephropathy (MN) and cancer is often mentioned in textbooks but poorly substantiated, and the characteristics of cancer-associated MN are unknown. To address these questions, we studied a cohort of 240 patients with MN, among them 24 had malignancy at the time of renal biopsy or within a year thereafter. The incidence of cancer was significantly higher in these patients than in the general population (standardized incidence ratio 9.8 [5.5-16.2] for men and 12… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 18 CITATIONS

Glomerular diseases and cancer: evaluation of underlying malignancy

  • Journal of Nephrology
  • 2015
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Effect of RAAS Inhibition on the Incidence of Cancer and Cancer Mortality in Patients with Glomerulonephritis

  • Journal of Korean medical science
  • 2011
VIEW 6 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Primary Membranous Nephropathy.

  • Clinical journal of the American Society of Nephrology : CJASN
  • 2017
VIEW 2 EXCERPTS
CITES BACKGROUND

Cancer risk after cyclophosphamide treatment in idiopathic membranous nephropathy.

  • Clinical journal of the American Society of Nephrology : CJASN
  • 2014
VIEW 2 EXCERPTS
CITES BACKGROUND